Translate
Lexaria Bioscience Corp
About
Lexaria Bioscience Corp (NASDAQ:LEXX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
Apr 15 2026
Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property
Apr 1 2026
Lexaria to Begin New Human Clinical Study in GLP-1
Mar 4 2026
Lexaria Announces New R&D Plans for 2026
Feb 5 2026
Lexaria Announces Positive Final Results From Human Pilot Study #5
Financials
Revenue
$522 K
Market Cap
$22.52 M
EPS
-0.57